Immune checkpoint inhibitors by mechanism

Drug mechanism	Drug name
Anti-PD-1	Cemiplimab Dostarlimab Nivolumab Pembrolizumab Penpulimab Retifanlimab Tislelizumab Toripalimab
Anti-PD-L1	Atezolizumab Avelumab Cosibelimab Durvalumab
Anti-CTLA-4	Ipilimumab Tremelimumab
Anti-LAG-3/anti-PD-1	Relatlimab and nivolumab

Graphic 130841 Version 10.0